Atlas Trials

Hydralazine as a Demethylating Agent in Rectal Cancer

Clinical trial NCT00575640 · WITHDRAWN

Trial details

NCT number
NCT00575640
Sponsor
University of Arkansas
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2004-11-01
Primary completion
2008-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.